The Journal of Allergy and Clinical Immunology
Volume 122, Issue 2 , Pages 249-250 , August 2008

The elite athlete: Yes, with allergy we can

  • Sergio Bonini, MD

      Affiliations

    • Second University of Naples, Rome, Italy
    • Corresponding Author InformationReprint requests: Sergio Bonini, MD, Second University of Naples, Via Ugo de Carolis 59, Rome 00136, Italy.
    • ,
  • Timothy Craig, DO

      Affiliations

    • Pennsylvania State University, Allergy, Asthma and Immunology, Hershey, Pa

Received 23 May 2008 ,Revised 14 June 2008 ,Accepted 17 June 2008.

  • Image Result

    World Anti-Doping Agency rules for antiallergic drugs. WADA, World Anti-Doping Agency; TUE, Therapeutic Use Exemption; A-TUE, Abbreviated Therapeutic Use Exemption; IT, immunotherapy.

    World Anti-Doping Agency rules for antiallergic drugs. WADA, World Anti-Doping Agency; TUE, Therapeutic Use Exemption; A-TUE, Abbreviated Therapeutic Use Exemption; IT, immunotherapy.

 Supported by the Italian Ministry of Health, Commission for Vigilance and Control of Doping (S.B.).

 Disclosure of potential conflict of interest: S. Bonini has a research appointment at the Institute of Neurobiology and Molecular Medicine, Italian National Research Council; is a member of the Research and Development Commission of the Italian Drug Agency; and has received research grants, consultancies, and honoraria from participation in speakers' bureaus for Alcon, Allergopharma, Allergy Therapeutics, ALK, Almirall, Aventis, AstraZeneca, Bioallergy, Bioxell, GlaxoSmithKline, Lofarma, Merch Sharp and Dohme, Novartis, Pfizer, Sanofi-Synthelabo, Schering-Plough, Stallaergens, UCB, and Zambon. T. Craig has declared that he has no conflict of interest.

PII: S0091-6749(08)01146-9

doi: 10.1016/j.jaci.2008.06.020

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 2 , Pages 249-250 , August 2008

Article Tools

* Image Usage & Resolution